HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
Status:
Completed
Trial end date:
2017-06-30
Target enrollment:
Participant gender:
Summary
STRIDE2 is a longitudinal, non-randomized study of individuals living with HIV who are
dependent on opioids. This study is funded by the National Institute on Drug Abuse
(R01DA030768, Altice, PI; Taxman & Lawson, Co-PIs) and is being conducted by George Mason
University, Yale University, and Howard University.
Details
Lead Sponsor:
Yale University
Collaborators:
George Mason University Howard University National Institute on Drug Abuse (NIDA)